BackgroundCheck.run
Search For

Kevin S Campos, 40Santa Monica, CA

Known as:
Kevin Sauveur Campos Kevin Sauveur Gorton Campos Kevin S Camop Kevin Gorton Campos Kevin Gorton
Related to:
Mark J Feist 54 Bruno M Campos 71 Sean D Campos 37 Lorle E Campos 71 Candace A Campos 44 Sean Campos

Kevin Campos Phones & Addresses

Santa Monica, CA   

Culver City, CA   

Newport Beach, CA   

San Francisco, CA   

Princeton, NJ   

Get Report
Control this profile

Mentions for Kevin S Campos

Career records & work history

Medicine Doctors

Kevin M. Campos

Specialties:
Emergency Medicine
Work:
Moses H Cone Memorial Hospital Emergency Medicine
1200 N Elm St, Greensboro, NC 27401
336-8322945 (phone) 336-8327835 (fax)
Education:
Medical School
Wake Forest University School of Medicine
Graduated: 2006
Languages:
English
Description:
Dr. Campos graduated from the Wake Forest University School of Medicine in 2006. He works in Greensboro, NC and specializes in Emergency Medicine. Dr. Campos is affiliated with Moses H Cone Memorial Hospital.

Kevin Campos resumes & CV records

Resumes

Kevin Campos Photo 47

Kevin Campos - San Gabriel, CA

Work:
Office Depot - Rosemead, CA Feb 2013 to Jul 2013
Customer Service Represntative Pizza Hut - Pasadena, CA Nov 2010 to Feb 2013
Store Manager Mc Donald's Restaurant - South El Monte, CA Jul 2008 to Jun 2010
Customer Service Representative Saint Anthony Church 2007 to 2007
Snack bar assistant during football tournament Saint Anthony Church - San Gabriel, CA 2006 to 2007
VOLUNTEER Pizza stand assistant Sep 2006 to Nov 2006 Saint Anthony Church 2006 to 2006
Clean up assistant for football tournament
Education:
Los Angeles Trade Tech College - Los Angeles, CA 2012 to 2014
Associate's in Microcomputer Technician (IT Work) Rosemead High School - Rosemead, CA Jan 2008 to Jun 2008 Don Bosco Technical Institute - Montebello, CA Sep 2004 to Dec 2007

Publications & IP owners

Us Patents

Formation Of Tetra-Substituted Enamides And Stereoselective Reduction Thereof

US Patent:
7629470, Dec 8, 2009
Filed:
Jul 1, 2005
Appl. No.:
11/629005
Inventors:
Kevin R. Campos - Berkeley Heights NJ, US
Artis Klapars - Scotch Plains NJ, US
J. Christopher McWilliams - Hoboken NJ, US
C. Scott Shultz - Maplewood NJ, US
Debra J. Wallace - Scotch Plains NJ, US
Alex M. Chen - Metuchen NJ, US
Lisa F. Frey - Somerset NJ, US
Andrey V. Peresypkin - Cranford NJ, US
Yaling Wang - Westfield NJ, US
Robert M. Wenslow - Cream Ridge NJ, US
Cheng-Yi Chen - Plainsboro NJ, US
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
C07D 213/63
US Classification:
546290
Abstract:
The present invention is directed to a practical process for the preparation of an enamide (II) by palladium catalyzed coupling of a primary amide (IV) with a compound of structural formula (III), as shown below: As well as to crystalline forms of a compound produced by this process, in particular, an anhydrous crystal form, Form B, and crystalline solvates falling into three patterns, Type 1, Type 2, and Type 3, and crystalline intermediate compounds produced in the process. Still further, the present invention relates to the stereoselective reduction of the tetrasubstituted enamide (II) to the corresponding amide (I).

Process For The Preparation Of Pgd2 Antagonist

US Patent:
2003019, Oct 23, 2003
Filed:
Jun 6, 2003
Appl. No.:
10/398741
Inventors:
Robert Larsen - Rahway NJ, US
Dongwei Cai - Rahway NJ, US
Michel Journet - Rahway NJ, US
Kevin Campos - Rahway NJ, US
International Classification:
C07D333/72
US Classification:
549/055000
Abstract:
The present invention provides an efficient process for the preparation of benzothiophenecarboxamide PGD2 antagonist, S-5751.

Process For Making Lactam Tachykinin Receptor Antagonists

US Patent:
2009024, Oct 1, 2009
Filed:
Aug 3, 2007
Appl. No.:
12/309999
Inventors:
Kevin R. Campos - Berkeley Heights NJ, US
Cheng Chen - Plainsboro NJ, US
Hideaki Ishibashi - Ibaraki, JP
Shinji Kato - Ibaraki, JP
Artis Klapars - Edison NJ, US
Yoshinori Kohmura - Ibaraki, JP
David J. Pollard - Monroe NJ, US
Akihiro Takezawa - Ibaraki, JP
Jacob H. Waldman - Westfield NJ, US
Debra Wallace - Herts, GB
Nobuyoshi Yasuda - Mountainside NJ, US
International Classification:
C07D 207/24
US Classification:
548550
Abstract:
The present invention is directed to a process for preparing α,α disubstituted γ-lactam derivatives of formula (I) that are useful as neurokinin-1 (NK-1) receptor antagonists, and inhibitors of tachykinin and in particular substance P. The compounds are useful in the treatment of certain disorders, including emesis, urinary incontinence, depression, and anxiety.

Formation Of Tetra-Substituted Enamides And Stereoselective Reduction Thereof

US Patent:
2010004, Feb 18, 2010
Filed:
Oct 22, 2009
Appl. No.:
12/603901
Inventors:
KEVIN R. CAMPOS - Berkeley Heights NJ, US
Artis Klapars - Scotch Plains NJ, US
J. Christopher McWilliams - Hoboken NJ, US
C. Scott Shultz - Maplewood NJ, US
Debra J. Wallace - Scotch Plains NJ, US
Alex M. Chen - Metuchen NJ, US
Lisa F. Frey - Somerset NJ, US
Andrey V. Peresypkin - Cranford NJ, US
Yaling Wang - Westfield NJ, US
Robert M. Wenslow - Cream Ridge NJ, US
Cheng-Yi Chen - Plainsboro NJ, US
International Classification:
C07D 211/72
C07C 233/00
US Classification:
546300, 564123
Abstract:
The present invention is directed to a practical process for the preparation of an enamide (II) by palladium catalyzed coupling of a primary amide (IV) with a compound of structural formula (III), as shown below: As well as to crystalline forms of a compound produced by this process, in particular, an anhydrous crystal form, Form B, and crystalline solvates falling into three patterns, Type 1, Type 2, and Type 3, and crystalline intermediate compounds produced in the process. Still further, the present invention relates to the stereoselective reduction of the tetrasubstituted enamide (II) to the corresponding amide (I).

Synthesis And Crystalline Forms Of Cb-1 Antagonist/Inverse Agonist

US Patent:
2010029, Nov 18, 2010
Filed:
Oct 20, 2008
Appl. No.:
12/681797
Inventors:
Kevin R. Campos - Berkeley Heights NJ, US
Cheng-Yi Chen - Plainsboro NJ, US
Jennifer R. Foley - Garwood NJ, US
Michael Hillier - Libertyville IL, US
Wendy S. Jen - Fanwood NJ, US
Amude M. Kassim - Monmouth Junction NJ, US
Artis Klapars - Edison NJ, US
Andrey V. Peresypkin - Cambridge MA, US
Thorsten Rosner - Berkeley Heights NJ, US
Cecile G. Savarin - Newbury Park CA, US
Matthew Tudge - Chatham NJ, US
Narayan Variankaval - Plainsboro NJ, US
Vicky Vydra - Tinton Falls NJ, US
Dalian Zhao - Fanwood NJ, US
International Classification:
A61K 31/4245
C07D 413/10
C07D 271/113
C07C 255/53
A61P 3/04
A61P 3/10
A61P 25/28
US Classification:
514364, 548144, 558423
Abstract:
The present invention relates to a process for producing crystalline 3-[(1S)-1-(1-{(S)-(4-chlorophenyl)[3-(5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)phenyl]methyl}azetidin-3-yl)-2-fluoro-2-methyl-propyl]-5-fluorobenzonitrile, and novel salts, solvates, hydrates and polymorphs thereof.

Process For Making Beta 3 Agonists And Intermediates

US Patent:
2021022, Jul 22, 2021
Filed:
Jan 22, 2021
Appl. No.:
17/155982
Inventors:
- Rahway NJ, US
Kevin CAMPOS - Berkeley Heights NJ, US
Edward CLEATOR - Cambridge, GB
Robert F. DUNN - Towaco NJ, US
Andrew GIBSON - Hoddesdon, GB
R. Scott HOERRNER - Westfield NJ, US
Stephen KEEN - Hoddesdon, GB
Dave LIEBERMAN - Hoddesdon, GB
Zhuqing LIU - Edison NJ, US
Joseph LYNCH - Plainfield NJ, US
Kevin M. MALONEY - Piscataway NJ, US
Feng XU - Staten Island NY, US
Nobuyoshi YASUDA - Mountainside NJ, US
Naoki YOSHIKAWA - Hyogo, JP
Yong-Li ZHONG - Edison NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07D 487/04
A61K 31/4196
A61K 31/519
C07D 403/12
C07D 207/09
C07D 263/06
Abstract:
The present invention is directed to processes for preparing beta 3 agonists of Formula (I) and Formula (II) and their intermediates. The beta 3 agonists are useful in the treatment of certain disorders, including overactive bladder, urinary incontinence, and urinary urgency.

Process For Making Beta 3 Agonists And Intermediates

US Patent:
2020029, Sep 17, 2020
Filed:
Feb 20, 2020
Appl. No.:
16/795745
Inventors:
- Rahway NJ, US
Kevin CAMPOS - Berkeley Heights NJ, US
Edward CLEATOR - Cambridge, GB
Robert F. DUNN - Towaco NJ, US
Andrew GIBSON - Hoddesdon, GB
R. Scott HOERRNER - Westfield NJ, US
Stephen KEEN - Hoddesdon, GB
Dave LIEBERMAN - Hoddesdon, GB
Zhuqing LIU - Edison NJ, US
Joseph LYNCH - Plainfield NJ, US
Kevin M. MALONEY - Piscataway NJ, US
Feng XU - Staten Island NY, US
Nobuyoshi YASUDA - Mountainside NJ, US
Naoki YOSHIKAWA - Hyogo, JP
Yong-Li ZHONG - Edison NJ, US
International Classification:
C07D 207/09
C07D 207/08
C12P 17/10
Abstract:
The present invention is directed to a process for preparing a compound of formula I-11 through multiple-step reactions:

Process For Making Beta 3 Agonists And Intermediates

US Patent:
2020003, Jan 30, 2020
Filed:
Oct 1, 2019
Appl. No.:
16/590180
Inventors:
- Rahway NJ, US
Kevin CAMPOS - Berkeley Heights NJ, US
Edward CLEATOR - Cambridge, GB
Robert F. DUNN - Towaco NJ, US
Andrew GIBSON - Hoddesdon, GB
R. Scott HOERRNER - Westfield NJ, US
Stephen KEEN - Hoddesdon, GB
Dave LIEBERMAN - Hoddesdon, GB
Zhuqing LIU - Edison NJ, US
Joseph LYNCH - Plainfield NJ, US
Kevin M. MALONEY - Piscataway NJ, US
Feng XU - Staten Island NY, US
Nobuyoshi YASUDA - Mountainside NJ, US
Naoki YOSHIKAWA - Hyogo, JP
Yong-Li ZHONG - Edison NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07D 487/04
A61K 31/4196
A61K 31/519
C07D 403/12
C07D 207/09
C07D 263/06
Abstract:
The present invention is directed to processes for preparing beta 3 agonists of Formula (I) and Formula (II) and their intermediates. The beta 3 agonists are useful in the treatment of certain disorders, including overactive bladder, urinary incontinence, and urinary urgency.

Possible Relatives

Cynthia Campos  David A Campos  Daysi Y Campos  Deanna K Campos  Daisy D Campos  Dalia S Campos  Damaris L Campos  Kevin T Johnson  Kevin Stamps  Kevin Stanberry 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.